Atlas Trials

High-dose Use of rhTPO in CIT Patients

Clinical trial NCT03633019 · UNKNOWN

Trial details

NCT number
NCT03633019
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Thrombocytopenia
Start date
2018-09-28
Primary completion
2019-11-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.